Restart Life Sciences Corp.
NMLSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $87 | $165 | $243 | $11 |
| Short-Term Investments | $52 | $97 | $145 | $159 |
| Receivables | $7 | $7 | $17 | $11 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $146 | $269 | $406 | $181 |
| Property Plant & Equip (Net) | $8 | $8 | $9 | $9 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $8 | $8 | $9 | $9 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $153 | $278 | $414 | $190 |
| Liabilities | – | – | – | – |
| Payables | $0 | $137 | $148 | $194 |
| Short-Term Debt | $0 | $0 | $0 | $80 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $302 | $78 | $0 | $215 |
| Total Curr. Liab. | $302 | $215 | $148 | $489 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $302 | $215 | $148 | $489 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $51,689 | $51,594 | $51,421 | $50,516 |
| Retained Earnings | -$60,298 | -$60,087 | -$59,883 | -$59,064 |
| AOCI | $8,460 | $8,555 | $8,728 | $8,249 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$148 | $63 | $266 | -$299 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $153 | $278 | $414 | $190 |
| Net Debt | -$87 | -$165 | -$243 | $69 |